You are here : Home / Funding Opportunities

Funding Opportunities

 

 

  1. Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, piloting innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system-related function and disorders throughout life, relevant to LMICs. Research on the full spectrum of neuro-health, neurological, neuromuscular, sensory, neuropsychiatric, cognitive, behavioral and neurodevelopmental function and disorders may span the full range of science from basic to clinical to translation and implementation research. Scientists in LMIC institutions may partner with scientists in other LMIC institutions and/or U.S. institutions . Income categories are defined by the World Bank at http://data.worldbank.org/about/country-classifications/country-and-lending-groups).

Link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-098.html

Application deadline:

November 15, 2022,

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

 

  1. Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to advance research to discover and validate novel biomarkers of Tuberculosis (TB) infection and subsequent risk of progression to TB disease in young children with and without HIV.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-015.html

Application deadline: June 08, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  1. Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 – Clinical Trial Optional)

The purpose of this funding opportunity announcement (FOA) is to support research examining the potential contributions of mobile DNA elements and addictive substances in HIV integration, reservoir formation, and maintenance in the brain. NIDA is specifically interested in studies exploring the contributions of molecular, genetic, and epigenetic factors in HIV integration, reservoir formation, and maintenance in microglia and/or the brain in the context of addiction.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-003.html

Application deadline: August 03, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  1. Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites implementation research applications to develop, optimize, and test innovative theory-based strategies to integrate mental and physical health care within health care systems in low-and middle-income countries (LMICs). This FOA aims to support innovative research for implementing, scaling up, and financially sustaining integrated mental health care models to ultimately increase demand and utilization, quality, access, and availability of mental health care. This FOA is also expected to contribute to the long-term goals of strengthening the sustainable research capacity in LMICs and enhancing the potential for multidirectional knowledge and the exchange of research advancements. NIMH encourages partnerships between institutions in LMICs and high-income-countries (HICs).

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-003.html

Application deadline: June 22, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  1. BRAIN Initiative: Targeted BRAIN Circuits Projects- Targeted BCP (R01 Clinical Trial Not Allowed)

This FOA solicits applications for research projects that seek to understand how circuit activity gives rise to mental experience and behavior using innovative, methodologically-integrated approaches. The goal is to support adventurous projects that can realize a potentially transformative outcome within 5 years. Applications are expected to address circuit function in the context of specific behaviors or neural systems, such as sensation, perception, attention, reasoning, intention, decision-making, emotion, navigation, communication, or homeostasis. Projects should link theory, data analysis, and/or computational approaches to experimental design and should produce predictive models (conceptual or quantitative). Projects should aim to improve the understanding of circuits of the central nervous system by systematically controlling stimuli and/or behavior while actively recording and/or manipulating dynamic patterns of neural activity. Diverse species or experimental systems and a cross-species/comparative approach are welcome and should be chosen based on their power to address the specific question at hand and to reveal generalizable and fundamental neuroscience principles.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-026.html

Application deadline: July 01, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

 

  1. Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective approaches to biomedical research education and mentoring that will keep pace with the rapid evolution of the research enterprise. This Neuroscience Doctoral Readiness Program (DR Program) expects that the proposed research education programs will incorporate extensive research experiences within the participating NIH Institutes missions and well-designed courses for skills development and education to prepare recent baccalaureates from diverse backgrounds to transition into and complete rigorous, research-focused doctoral degree programs (e.g., Ph.D., M.D./Ph.D., or D.D.S./Ph.D.) in biomedical fields.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-035.html

Application deadline: April 19, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  1. HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical

The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery of candidate biomarkers or biomarker signatures for pain that can be used to facilitate the testing of non-opioid pain therapeutics in Phase II clinical trials. The biomarkers or biomarker signature will be developed through clinical research specifically focused on the identification of pain biomarkers or biosignatures that predict and/or monitor response to pain therapeutics. The resulting biomarkers or biomarker signatures may be focused on a single pain condition or on several pain conditions with common underlying pathophysiology. Applications to identify biomarkers or biomarker signatures that predict or monitor a therapeutic response across several related pain conditions should feature Multiple Principal Investigator (MPI)-led teams that represent each of the related pain conditions and associated clinical networks. Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-035.html

Application deadline: March 11, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

8. Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative pilot research that will inform and support the delivery of high-quality, continuously improving mental health services to benefit the greatest number of individuals with, or at risk for developing, a mental illness. This announcement invites applications for non-clinical trial pilot projects that address NIMH strategic priorities to strengthen the public health impact of NIMH-supported research as described in Goal 4 of the NIMH Strategic Plan.

Link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-082.html

Application date line:

June 16, 2022,

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

9. Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required)

NIMH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). See “Determination that a Public Health Emergency Exists Nationwide as the Result of the 2019 Novel Coronavirus” as renewed in “Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of Coronavirus Disease 2019 (COVID-19) Pandemic“. This Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive mental health research questions related to COVID-19, including broader secondary impacts of the pandemic as well as research on the intersection of mental health, COVID-19, and HIV. Research supported will improve public health in the near term by informing responses to the current pandemic through rapid acceleration of research to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions to respond to new and worsening mental illness and HIV-related outcomes among those who experience COVID-19 as well as the broader population impacted by the pandemic. All research is anticipated to focus on particularly vulnerable populations based on existing evidence of increased mental health symptoms and illness and preexisting health disparities.

Link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-112.html

Application Date Line: April 25, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

10. HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes & Cells (U19 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement is to support research that uses human tissue or cells to generate comprehensive datasets for the discovery and characterization of functional genetic elements, epigenetic signatures, and molecular/cellular pathways that underlie human pain transduction, transmission, and processing. This FOA will support concerted multidisciplinary team science efforts that apply large-scale high-throughput approaches on tissues involved in human pain processing as part of the NIH HEAL Initiative’s Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins, and the Nature of Human Pain (PRECISION Human Pain). U19 Centers will operate as a cooperative network to promote collaboration and coordination of research activities. U19 Centers will also coordinate with the U24 HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center that will curate, harmonize, and integrate datasets generated by this U19 research program.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-018.html

Application Date Line: March 17, 2022,

11. Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) aims to identify and support collaborative projects that will comprehensively delineate ocular surface innervation – from corneal sensation to pain circuits and tearing reflexes. The Request for Applications (RFA) aims to explore this system at three levels of analysis: morphologic, molecular, and functional. Successful projects will incorporate and integrate at least two of these levels of analysis, and ideally all three. Collaborative multi-disciplinary teams are expected with investigators having complementary areas of expertise. The premise of this FOA is that such basic biology will facilitate a deeper understanding of related pathobiology including neuropathic ocular pain and dry eye disease that will lay a foundation for future translational and clinical research on the anterior segment of the eye. 

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-21-004.html

Application Date Line: March 07, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.


oral sex with hotties movie sex scene teen pussy www xxvideo com More than just erotic film Anal with hot Latina babe Foxy hottie loves anal